Abstract:The purpose of this article is to update the changes to the author's protocols used to manage acute filler related vascular events from those previously published in this journal. For lack of a better term, this new protocol has been called the High Dose Pulsed Hyaluronidase (HDPH) protocol for vascular embolic events with hyaluronic acid (HA) fillers. The initial protocol used involved many different modalities of treatment. The current protocol is exceedingly simple and involves solely the use of hyaluronidase in repeated high doses. Despite the simplicity of the treatment, it has proven itself to be very successful over the past two years of clinical use. There has been no partial or complete skin loss associated with this protocol since its implementation if the protocol was implemented within 2 days of the ischemic event onset. The protocol involves diagnosis and repeated administration of relatively high doses hyaluronidase (HYAL) into the ischemic tissue repeated hourly until resolution (as detected clinically through capillary refill, skin color, and absence of pain). The dosage of HYAL varies as the amount of ischemic tissue, consistent with the new underlying hypothesis that we must flood the occluded vessels with a sufficient concentration of HYAL for a sufficient period of time in order to dissolve the HA obstruction to the point where the products of hydrolysis can pass through the capillary beds. Although vascular embolic events are rare, it is important to note that the face has higher risk and lower risk areas for filler treatment, but there are no "zero risk" areas with respect to filler treatments. Even with good anatomic knowledge and correct technique, there is still some nonzero risk of vascular embolic events (including highly skilled, experienced injectors). However, with careful low pressure, low volume injection technique, and adequate preparation for treatment of acute vascular events, the risk is quite manageable and the vast majority of adverse events are very treatable with an excellent prognosis, with a few exceptions. This new protocol offers excellent results, but requires further research to determine optimal parameters for various HA fillers.

Efficacy of Superselective Intra-arterial Recanalization of Embolized Arteries Resulting from Facial Hyaluronic Acid Injection

Superselective Arterial Hyaluronidase Thrombolysis is an Effective Treatment for Hyaluronic Acid-Induced Retinal Artery Occlusion: Study in a Rabbit Model

Facial Artery Branch Thrombolysis for Nasal Vascular Embolism Induced by Hyaluronic Acid Injection

Cerebral infarction following facial autologous fat transplantation: report of two cases

Retinal Branch Artery Embolization Following Hyaluronic Acid Injection: A Case Report.

Embolization of Ophthalmic Artery Induced By Ear Hyaluronic Acid Injection

Plasma Hyaluronan and Collateral Development in Patients with Coronary Artery Disease

Superselective Arterial Hyaluronidase Thrombolysis is Not an Effective Treatment for Hyaluronic Acid–Induced Retinal Artery Occlusion: Study in a Rabbit Model

Super-Selective Intra-arterial Thrombolytic Therapy for Peripheral Facial Paralysis After Postauricular Hyaluronic Acid Injection for the Esthetic Correction of Lying Ears

Exploring Super-Selective Intra-Arterial Thrombolysis for Autologous Fat Injection–Induced Vision Loss

Complications after Polyacrylamide Hydrogel Injection for Facial Soft-Tissue Augmentation in China

Treatment of Facial Artery Embolization Caused by Polycaprolactone-based Dermal Filler with a Regimen Including 5-Fluorouracil

Severe Vascular Complications Caused by Facial Autologous Fat Grafting: A Critical Review

An experimental study of the vascular embolism caused by recombinant type III collagen implants and hyaluronic acid

Cross‐linked hyaluronic acid filler hydrolysis with hyaluronidase: Different settings to reproduce different clinical scenarios

New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events

Reversal of Post-filler Vision Loss and Skin Ischaemia with High-Dose Pulsed Hyaluronidase Injections

Embolization of a common carotid aneurysm with rhVEGF coupled to a pH-responsive chitosan in a rat model: Laboratory investigation

Retrospective clinical study on the efficacy and complications of interventional embolization in the treatment of scalp arteriovenous fistula

Successful Treatment of Hyaluronic Acid-Induced Facial Necrosis With Intravenous Dinoprostone

Retinal artery occlusion after facial filler injection in a patient with patent foramen ovale: a case report and literature review